Neuroimmune endocrine effects of antidepressants
Marco Antonioli, Joanna Rybka, LA CarvalhoPsychoimmunology Translational Laboratory, Health Science Research Centre, Roehampton University, London, UKAbstract: Antidepressant pharmacotherapy is to date the most often used treatment for depression, but the exact mechanism of action underlying its the...
Enregistré dans:
Auteurs principaux: | Antonioli M, Rybka J, Carvalho LA |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2012
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/b0131f61dba64a15ba84f94212b1c836 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Antidepressant therapy with milnacipran and venlafaxine
par: Lucilla Mansuy
Publié: (2010) -
Milnacipran: a unique antidepressant?
par: Siegfried Kasper, et autres
Publié: (2010) -
Augmentation with antidepressants in schizophrenia treatment: benefit or risk
par: Mao YM, et autres
Publié: (2015) -
Examining the relationship between adherence and satisfaction with antidepressant treatment
par: Aljumah K, et autres
Publié: (2014) -
Influence of drug treatment with antidepressants and antipsychotics on plasma urea levels
par: Lozano Ortiz R
Publié: (2012)